Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients
Status:
Terminated
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of ribavirin, administered
as an aerosol, in preventing progression of upper respiratory tract RSV infection to RSV
pneumonia in bone marrow and peripheral blood transplant recipients.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)